US Prescription trends of antihistamines for atopic dermatitis, 2011-2016

Swati Garg, Jeffrey Zhao, Kyle Tegtmeyer, Parth Shah, Peter A. Lio

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


Antihistamine use for primary treatment of atopic dermatitis (AD) is not recommended, but current guidelines state that sedating antihistamines are favored over non-sedating antihistamines for relief of burdensome pruritus. We analyzed the National Ambulatory Medical Care Survey data to compare use of antihistamines between dermatologists and non-dermatologists. Overall, dermatologists are more likely to prescribe sedating than non-sedating antihistamines when compared to non-dermatologists (P <.001, δabs = 0.45). Patients under 21 years old (P =.03, δabs = 0.10) and Black patients (P <.001, δabs = 0.19) were also more likely to receive sedating antihistamines than non-sedating antihistamines. These findings highlight the differential prescribing practices for atopic dermatitis among physicians.

Original languageEnglish
Pages (from-to)324-326
Number of pages3
JournalPediatric Dermatology
Issue number1
StatePublished - 1 Jan 2021
Externally publishedYes


  • AAD
  • antihistamine
  • atopic dermatitis


Dive into the research topics of 'US Prescription trends of antihistamines for atopic dermatitis, 2011-2016'. Together they form a unique fingerprint.

Cite this